Biologikatherapie der juvenilen idiopathische Arthritis im jungen Erwachsenenalter
Authors:
- 7 August 2014
- journal article
- leitthema
- Published by Springer Nature in Zeitschrift für Rheumatologie
- Vol. 73 (6) , 532-540
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Biologic treatment response among adults with juvenile idiopathic arthritis: results from the British Society for Rheumatology Biologics RegisterRheumatology, 2013
- Changes in Treatment Adherence and Glycemic Control During the Transition to Adolescence in Type 1 DiabetesDiabetes Care, 2012
- Aggressive Combination Drug Therapy in Very Early Polyarticular Juvenile Idiopathic Arthritis (ACUTE–JIA): a multicentre randomised open-label clinical trialAnnals of the Rheumatic Diseases, 2011
- Current Medical Treatments for Juvenile Idiopathic ArthritisFrontiers in Pharmacology, 2011
- Disease activity and disability in children with juvenile idiopathic arthritis one year following presentation to paediatric rheumatology. Results from the Childhood Arthritis Prospective StudyRheumatology, 2009
- Predictors of early inactive disease in a juvenile idiopathic arthritis cohort: Results of a Canadian multicenter, prospective inception cohort studyArthritis Care & Research, 2009
- The German etanercept registry for treatment of juvenile idiopathic arthritisAnnals of the Rheumatic Diseases, 2004
- Outcome in adults with juvenile idiopathic arthritis: A quality of life studyArthritis & Rheumatism, 2003
- Long‐term outcome in patients with juvenile idiopathic arthritisArthritis & Rheumatism, 2002
- Methotrexate in Resistant Juvenile Rheumatoid ArthritisNew England Journal of Medicine, 1992